HSBC Holdings’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-100,904
| Closed | -$11.6M | – | 3198 |
|
|
2024
Q3 | $11.6M | Sell |
100,904
-114,058
| -53% | -$12.9M | 0.01% | 877 |
|
|
2024
Q2 | $23M | Buy |
+214,962
| New | +$21.6M | 0.01% | 644 |
|
|
2023
Q1 | – | Sell |
-73,350
| Closed | -$6.63M | – | 2932 |
|
|
2022
Q4 | $6.63M | Buy |
+73,350
| New | +$6.18M | 0.01% | 1136 |
|
|
2021
Q4 | – | Sell |
-5,458
| Closed | -$446K | – | 3323 |
|
|
2021
Q3 | $446K | Buy |
+5,458
| New | +$491K | ﹤0.01% | 2324 |
|
|
2019
Q2 | – | Sell |
-2,911
| Closed | -$251K | – | 2813 |
|
|
2019
Q1 | $251K | Buy |
+2,911
| New | +$234K | ﹤0.01% | 2437 |
|
|
2018
Q2 | – | Sell |
-3,077
| Closed | -$223K | – | 2668 |
|
|
2018
Q1 | $223K | Sell |
3,077
-2,426
| -44% | -$185K | ﹤0.01% | 2347 |
|
|
2017
Q4 | $414K | Buy |
5,503
+1,266
| +30% | +$95.5K | ﹤0.01% | 1573 |
|
|
2017
Q3 | $326K | Sell |
4,237
-175
| -4% | -$13.2K | ﹤0.01% | 1906 |
|
|
2017
Q2 | $330K | Sell |
4,412
-11,753
| -73% | -$833K | ﹤0.01% | 1828 |
|
|
2017
Q1 | $1.07M | Buy |
16,165
+2,937
| +22% | +$196K | ﹤0.01% | 1392 |
|
|
2016
Q4 | $863K | Buy |
13,228
+9,987
| +308% | +$648K | ﹤0.01% | 1485 |
|
|
2016
Q3 | $230K | Buy |
3,241
+3,125
| +2,694% | +$228K | ﹤0.01% | 1865 |
|
|
2016
Q2 | $9K | Sell |
116
-3,257
| -97% | -$225K | ﹤0.01% | 2033 |
|
|
2016
Q1 | $219K | Sell |
3,373
-1,280
| -28% | -$87.1K | ﹤0.01% | 1890 |
|
|
2015
Q4 | $359K | Buy |
+4,653
| New | +$370K | ﹤0.01% | 1799 |
|
|
2014
Q1 | – | Sell |
-6,886
| Closed | -$497K | – | 1781 |
|
|
2013
Q4 | $497K | Buy |
+6,886
| New | +$479K | ﹤0.01% | 1422 |
|
|
2013
Q3 | – | Sell |
-3,847
| Closed | -$244K | – | 1745 |
|
|
2013
Q2 | $244K | Buy |
+3,847
| New | +$250K | ﹤0.01% | 1391 |
|
Other funds holding NVS
